Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedAdded a Related topics section with MedlinePlus Genetics and updated the page revision from v3.5.4 to v3.5.5, indicating a minor metadata refresh.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRemoved the disease label 'Multiple Myeloma' under Conditions, the 'related topics' section header, and the 'MedlinePlus Genetics' resource link. This changes how the study's focus is presented and where users can access background health information on the page.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a maintenance update to the page's versioning metadata.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page now explicitly lists 'Multiple myeloma' as the condition. It adds a 'related topics' section with MedlinePlus Genetics as a linked resource.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a site update rather than any modification to the ClinicalTrials.gov study record content.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.5.2. Removed mentions of 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.5.0'.SummaryDifference0.2%

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.